Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000298665 is a long non-coding RNA gene located on chromosome 22, antisense to the protein-coding genes TRIOBP (TRIO and F-actin binding protein) and GGA1 (Golgi-associated, gamma adaptin ear containing, ARF binding protein 1)[4]. There is no evidence in current literature or databases that this transcript encodes a protein, participates in well-characterized biological pathways, or is involved in human disease. Its possible biological roles, such as regulation of the adjacent protein-coding genes, remain unproven and are not supported by current data. It is not considered a therapeutic target and lacks information about drug interactions, biomarker potential, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to TRIOBP and GGA1 (ENSG00000298665).